The company has received permission to import for sale and distribution of Durvalumab solution for an additional indication

The UK based-pharmaceutical giant is transitioning to the market by delisting American Depositary Shares from the Nasdaq index.

AstraZeneca has unveiled a tie-up with China’s CSPC Pharmaceutical Group to ramp up development of experimental weight loss and diabetes dru...

AstraZeneca will license experimental drugs for ‌obesity and weight-related conditions from CSPC Pharmaceutical Group and collaborate on add...

The deal is the largest of Starmer’s visit to China as Britain seeks to strengthen ties

British pharmaceutical giant AstraZeneca has announced plans to invest $15 billion in China over the next seven years. The investment, aimed...

ROCKVILLE, Md. and SHANGHAI, Jan. 18, 2026 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta"), a global clinical-stage biopharmaceutical com...

NATICK, Mass., Dec. 8, 2025 /PRNewswire/ -- Pillar Biosciences announced today an expansion of its existing laboratory access program with A...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 23, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a...

Deal to lower drug costs for Americans and shield the drugmaker from import tariffs was the culmination of efforts stretching back to Novemb...

The US president told reporters he didn't think the deal would have been possible without his 100-percent tariff threat.

By WILL WEISSERT, Associated PressWASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce i...

The British government should not get complacent about AstraZeneca's U.S. listing, as it paves the way for a full one in New York.

Drugs giant AstraZeneca has revealed plans to overhaul its US listing, but stressed it will keep its headquarters in the UK and remain on th...

AstraZeneca has asked the Supreme Court to hear its case challenging the Medicare Drug Price Negotiation Program created through the Inflati...